期刊文献+

MR多技术扫描检测活性心肌及其影像学对比的实验研究 被引量:2

An Experimental Study of Multimodality MR Imaging in Determination of Myocardial Viability Compared with SPECT, PET and Echocardiography
下载PDF
导出
摘要 目的评估各种影像学方法检测活性心肌的价值。材料与方法建立慢性心肌缺血模型猪10头,分别于制作模型前和后1~2月进行磁共振多技术扫描及小剂量多巴酚丁胺负荷超声心动图(LDDSE)、201Tl单光子发射计算机体层显像(201TlSPECT)、正电子发射体层显像(18FPET)检查,判断心肌缺血区和坏死区的大小,并与病理结果对照了解各种方法的敏感性、特异性。结果7头动物顺利完成所有检查,负荷磁共振电影扫描见10个(8.93%)节段为梗死心肌,6个(5.36%)节段为缺血心肌;心肌灌注扫描见34个(30.35%)节段缺血,心肌活性扫描见12个(10.71%)节段坏死。LDDSE检查见8个(7.14%)节段为梗死心肌,9个(8.04%)节段为缺血心肌。SPECT检查见9个(8.04%)节段为梗死心肌。PET检查见17个(15.18%)节段为梗死心肌。TTC染色见14个(12.50%)节段为梗死区。MR电影检出的坏死节段比TTC染色显示的节段少并有统计学意义(P=0.0455,Kappa=0.8100);MR活性扫描检出的坏死节段比TTC染色显示的坏死节段略少但无统计学意义(P=0.1573,Kappa=0.9130)。LDDSE检出的坏死节段较TTC染色显示的节段少并有统计学意义(P=0.0140,Kappa=0.7000);PET检出的坏死节段多于磁共振活性扫描(P=0.0253,Kappa=0.8028)和MR电影扫描(P=0.0082,Kappa=0.7079)并有统计学意义;亦多于TTC染色显示的坏死节段(P=0.0833,Kappa=0.8879),但无统计学意义;SPECT检出的坏死节段比TTC染色显示的节段少并有统计学意义(P=0.0253,Kappa=0.7590)。以TTC染色结果为金标准,MRI电影、MRI活性扫描、LDDSE、SPECT、PET检出无活性心肌的敏感性、特异性分别为71.43%、100%;85.71%、100%;57.10%、100%;64.29%、100%;100%、96.94%。结论MR多技术扫描可结合形态、功能及灌注多种方法检测活性心肌,清晰显示心肌梗死的位置、程度,并可对左室室壁运动进行直观显示,且价格相对PET便宜;磁共振和PET、病理结果均有较高一致性。PET高估心肌坏死范围,且不能判断心肌梗死的透壁程度。SPECT和LDDSE低估心肌活性,而且亦不能显示心肌梗死的透壁程度。 Objective To evaluate the diagnostic value for myocardial viability by using various imaging methods. Materials and Methods Chronic myocardial ischemia animal model in 10 pigs were established and underwent with multimodality MR imaging, 18F fluorodeoxyglucose positron emission tomography (PET),^201 TI single photon emission computed tomography(SPECT) and low-dose dobutamine stress echocardiography (LDDSE) before and after 1 to 2 month modeling, respectively. The size of myocardial ischemia and necrosis were judged and compared with pathology results to assess the sensitivity and specificity of various imaging methods. Results 7 pigs were completed all examination successfully. Stress MRI detected 10 (8,93 % ) segments as necrosis, 6 (5.36%) segments were iscbemic. Perfusion was abnormal in 34(30.35% ) segments as ischemia. Delayed hyperenhancement was observed in 12( 10.71% ) segments as necrosis. LDDSE detected 8 (7.14 % ) segments as necrosis, 9 (8.04 % ) segments as isebemic. PET showed 17(15.18%) segments of myocardial necrosis. SPECT showed 9(8.04%) segments of myocardial necrosis. Triphenyl tetrazolium chlofide(TTC) determined 14( 12.50% ) segments of necrosis. Necrosis segments determined by PET significantly were more than that by contrast enhanced MR imaging ( P = 0.0253, Kappa = 0.8028) and cine MRI (P =0.0082, Kappa =0.7079), it was also more than TTC (P = 0.0833, Kappa = 0.8879), but had no significant statistic difference. Necrosis segments determined by SPECT significantly were less than that by TTC (P = 0. 0253, Kappa = 0.7590), which had significant statistic difference. Necrosis segments determined by cine MR significantly were less than that by TTC ( P = 0. 0455, Kappa = 0.8100). Necrosis segments determined by contrast enhanced MRI had no significant statistic difference with TTC ( P = 0. 1573, Kappa = 0.9130). Necrosis segments determined by LDDSE significantly were less than that by TTC ( P = 0.0140, Kappa = 0.7000), which had significant statistic difference. Using TTC as gold standard, the sensitivity and specificity of cine MRI, contrast enhanced MRI, LDDSE, SPECT and PET in the determination of unviable myocardium were 71.43% ; 100%;85.71%,100%; 57.10%, 100%; 64.29%,100%and 100%,96.94%, respectively. Conclusion Cardiac MRIcan combine with morphology, function and perfusion to determine viable myocardium, delineate the location and degree of necrosis myocardium clearly, demonstrate wall motion of left ventricular directly and cheaper than PET, MRI has high consistency with PET and pathology result. PET slightly overestimate extent of necrosis myocardium and can' t distinguish transmural necrosis from subendocardial necrosis. ^201TI single photon emission computed tomography and low dose dobutamine echocardiography underestimate myocardial viability, which can't show extent of infarction exactly.
出处 《临床放射学杂志》 CSCD 北大核心 2006年第4期374-378,共5页 Journal of Clinical Radiology
基金 国家自然科学基金资助项目(基金编号30270419)
关键词 磁共振成像 心肌活性 超声心动图 放射性核素 动物 Magnetic resonance imaging Myocardial viability Echocardiography Radionisotope Animals
  • 相关文献

参考文献9

  • 1朱海云,田建明,王莉,曾浩,黄胜东,徐训宇.磁共振多技术联合应用检测存活心肌的实验研究[J].临床放射学杂志,2005,24(3):264-269. 被引量:9
  • 2Wagner A,Mahrholdt H,Holly TA,et al.Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts:an imaging study.Lancet,2003,361:374.
  • 3张建,王铁,崔亮,王乐丰,武秀朵,刘枢,曲士颖,黄京伟.AMI患者直接与择期PTCA术后心肌活性及左室功能的研究[J].中华核医学杂志,2002,22(6):335-337. 被引量:7
  • 4Zamorano J,Delgado J,Almeria C,et al.Reason for discrepancies in identifying myocardial viability by thallium-201 redistribution,magnetic resonance imaging,and dobutamine echocardiography.Am J Cardiol,2002,90:455.
  • 5Nelson C,McCrohon J,Khafagi F,et al.Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography:a comparison with contrast-enhanced magnetic resonance imaging.J Am Coll Cardiol,2004,43:1248.
  • 6Baumgartner H,Porenta G,Lau YK,et al.Assessment of myocardial viability by dobutamine echocardiography,positron emission tomography and thallium-201 SPECT:correlation with histopathology in explanted heart.J Am Coll Cardiol.1998,15,32:1701.
  • 7王屹,杜湘珂,刘健,陈雷,孙燕萍.心肌灌注MRI和MR电影在急性冠状动脉综合征中的应用[J].中华放射学杂志,2002,36(8):702-706. 被引量:19
  • 8Kontos MC,Kurdziel KA,Ornato JP,et al.A nonischemic electrocardiogram does not always predict a small myocardial infarction:results with acute myocardial perfusion imaging.Am Heart J,2001,141:360.
  • 9Wagner A,Mahrholdt H,Holly TA,et al.Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts:an imaging study.Lancet.2003,361:374.

二级参考文献22

  • 1Lieu TA, Gurley RJ, Lundstrom T, et al. Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol, 1996, 27: 737-750.
  • 2Zahn R, Koch A, Rustige J, et al. Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. Am J Cardiol,1997,79:264-269.
  • 3Chen EQ, Maclntyre WJ, Go RT, et al. Myocardial viability studies using 18F-FDG SPECT: a comparison with 18F-FDG PET. J Nucl Med, 1997, 38: 582-586.
  • 4Hasegawa S, Uehara T, Yamaguchi H, et al. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability. J Nucl Med, 1999, 40: 1884-1892.
  • 5Dispersyn GD, Borgers M, Flameng W. Apoptosis in chronic hibernating myocardium: sleeping to death? Cardiovasc Res, 2000, 45:696
  • 6Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation, 1993, 87:1
  • 7Hillenbrand HB, Kim RJ, Parker MA,et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation, 2000, 102:1678
  • 8Choi KM, Kim RJ, Gubernikoff G,et al. Transmural extent of acute my ocardial infarction predicts long-term improvement in contractile function. Circulation, 2001, 104:1101
  • 9Lieven Van Hoe, Marc Vanderheyedn. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol, 2004, 182:95
  • 10Judd RM,Lugo-Olivieri CH,Arai M,et al.Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2day-old reperfused canine infarcts[].Circulation.1995

共引文献30

同被引文献12

  • 1Strauer BE, Brehm M, Zeus T,et al. Repair of infracted myocardium by autologous intracoronary monouclear bone marrow cell transplantation in humans. Circulation, 2002, 106 : 1913
  • 2Tse HF, Kwong YL, Chan KF,et al. Angiogenesis in ischaemic myocardium by intramyocantial autologous bone marrow mononudear cell implantation. Lancet, 2003, 361:47
  • 3Cerqueira MD, Weissman NJ, Dilsizian V,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart:a statement for heahhcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2002, 105:539
  • 4Rajnoch C, Chachques JC, Berrebi A,et al. Cellular therapy reverses myocantial dysfunction. J Thorac Cardiovasc Surg, 2001, 121:871
  • 5Chiu RC. Therapeutic cardiac angiogenesis and myogenesis: The promises and challenges on a new frontier. J Thorac Cardiovasc Surg, 2001, 122:851
  • 6Chachques JC, Cattadori B, Herreros J, et al. Treatment of heart failure with autologous skeletal myoblasts. Herz, 2002, 27:570
  • 7Toma C, Pittenger MF, Cahill KS,et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 2002, 105:93
  • 8Carmeliet P. Angiogenesis in health and disease. Nat Med, 2003, 9:653
  • 9刘东婷,马晓海,赵蕾,刘一祎,刘一,范占明.钆布醇在磁共振延迟增强成像诊断肥厚型心肌病中的应用[J].中国医学影像学杂志,2016,24(5):337-341. 被引量:12
  • 10陈军红,李东野,韩曙光,徐通达,王超凡,宣皓晨.延迟增强磁共振成像评价陈旧性心肌梗死患者存活心肌研究[J].实用放射学杂志,2018,34(11):1701-1704. 被引量:5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部